| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 05/12/2011 | US20110112073 Compositions and methods relating to heat shock transcription factor activating compounds and targets thereof |
| 05/12/2011 | US20110112066 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 05/12/2011 | US20110112038 Novel npr-b agonists |
| 05/12/2011 | US20110112016 Compositions and methods for modulating the immune system |
| 05/12/2011 | US20110112015 Use of glis3 for preparing functional pancreatic beta-cells |
| 05/12/2011 | US20110112011 Pharmaceutical compositions based on kinin b2 receptor antagonists and corticosteroids, and their use |
| 05/12/2011 | US20110111059 Compositions Comprising Quinazoline Derivatives, Preparation Methods and Uses Thereof |
| 05/12/2011 | US20110111007 Inhibition of retinal cell degeneration or neovascularization by cerium oxide nanoparticles |
| 05/12/2011 | US20110111006 Conveniently implantable sustained release drug compositions |
| 05/12/2011 | US20110110987 Agent for regenerating tympanic membrane or external auditory canal |
| 05/12/2011 | US20110110957 Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use |
| 05/12/2011 | US20110110944 Anti-alk1 antibodies and uses thereof |
| 05/12/2011 | US20110110934 Treatment of uveitis |
| 05/12/2011 | US20110110917 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis |
| 05/12/2011 | CA2780268A1 Ophthalmic formulations containing substituted gamma lactams and methods for use thereof |
| 05/12/2011 | CA2777352A1 A novel process for the preparation of prostaglandins and intermediates thereof |
| 05/12/2011 | CA2774054A1 Nutritional supplements for relief of dry eye |
| 05/11/2011 | EP2319925A2 Therapeutic uses of inhibitors of RTP801 |
| 05/11/2011 | EP2319870A2 Human antibodies that bind human IL-12 and methods for producing |
| 05/11/2011 | EP2319839A1 Quinazolinone derivatives and their use as CB agonists |
| 05/11/2011 | EP2319838A1 Therapeutic Molecules and Methods-1 |
| 05/11/2011 | EP2319831A1 Novel pyrrole derivative having, as substituents, ureide group, aminocarbonyl group and bicyclic group which may have substituent |
| 05/11/2011 | EP2319539A1 Prophylactic or therapeutic agent for axial myopia |
| 05/11/2011 | EP2319517A1 Use of prodrugs for ocular intravitreous administration |
| 05/11/2011 | EP2319516A1 Compounds for treating inflammatory and autoimmune disorders |
| 05/11/2011 | EP2319514A1 Stable aqueous solution composition containing sulfonamide compound |
| 05/11/2011 | EP2319511A2 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 05/11/2011 | EP2319493A2 Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent |
| 05/11/2011 | EP2318427A1 Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology |
| 05/11/2011 | EP2317999A2 Methods for modulating angiogenesis via dystrophin dp71 |
| 05/11/2011 | EP2317976A1 Methods and ophtalmic devices used in the treatment of ocular allergies |
| 05/11/2011 | EP1453916B1 Combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof |
| 05/11/2011 | EP1320520B1 Sulfonylguanidine |
| 05/11/2011 | CN1876152B A medicine for treating nervous deafness and preparation process thereof |
| 05/11/2011 | CN102056609A Pharmaceutical combination |
| 05/11/2011 | CN102050821A Novel imidazo(1,5-a)pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/11/2011 | CN102050812A 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| 05/11/2011 | CN102050811A 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure |
| 05/11/2011 | CN102050772A Bimatoprost crystal as well as preparation method and purposes thereof |
| 05/11/2011 | CN102048877A External ointment for treating various inflammations and scabies and malignant sores and preparation method thereof |
| 05/11/2011 | CN102048756A Use of human fat-derived mesenchymal stem cells in treatment of diseases in kidney and ocular fundus |
| 05/11/2011 | CN102048747A Tulathromycin composition used for treating or preventing pet bacterial diseases and preparation method thereof |
| 05/11/2011 | CN102048746A Application of dioscin in preventing and treating diabetic complications |
| 05/11/2011 | CN102048727A Application of formononetin in preparing of medicament for restricting angiogenesis |
| 05/11/2011 | CN101415407B Use of inhibitors of JUN N-terminal kinases to treat glaucoma |
| 05/11/2011 | CN101167778B Semen vaccariae extraction for inhibiting angiogenesis and preparation and application thereof |
| 05/10/2011 | USRE42353 Quinazoline derivatives and pharmaceutical compositions containing them |
| 05/10/2011 | US7939670 Nociceptin analogs |
| 05/10/2011 | US7939655 Process for preparing a sterile high molecular weight hyaluronic acid formulation |
| 05/10/2011 | US7939625 Somatostatin analogues |
| 05/10/2011 | US7939501 prevent eye irritation and discomfort; contains cationic polymeric preservative and buffer; amphipathic peptides effective against both gram-positive and gram-negative bacteria, and as antideposit agent for reducing cationic preservatives deposition |
| 05/10/2011 | US7939292 Modified heparinase III and methods of sequencing therewith |
| 05/10/2011 | CA2478335C Amino-methyl substituted tetracycline compounds |
| 05/10/2011 | CA2475498C Piperidine derivative and pharmaceutical composition comprising the same as active ingredient |
| 05/10/2011 | CA2467471C Derivatives of andrimid and moiramide b having antibacterial properties |
| 05/10/2011 | CA2463102C Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 05/10/2011 | CA2454976C Therapeutic agent for glaucoma comprising compound having pi3 kinase inhibitory action as active ingredient |
| 05/10/2011 | CA2436935C Serine protease inhibitors |
| 05/10/2011 | CA2419633C Substituted imidazoles as tafia inhibitors |
| 05/10/2011 | CA2416293C Somatostatin analogues |
| 05/05/2011 | WO2011053801A2 Methods and cosmetic preparations for the sustained delivery of therapeutic agents to the eye |
| 05/05/2011 | WO2011053768A2 System and method for stabilizing corneal tissue after treatment |
| 05/05/2011 | WO2011053569A1 Ophthalmic formulation and method of manufacture thereof |
| 05/05/2011 | WO2011050638A1 A crystalline form of bimatoprost, preparation method and use thereof |
| 05/05/2011 | WO2010031248A8 Thiazolium salt compound and the use of treating the protein aging disease |
| 05/05/2011 | US20110107443 Novel protein transduction domains derived from secretory leukocyte protease inhibitor |
| 05/05/2011 | US20110105625 Ophthalmic composition for contact lens |
| 05/05/2011 | US20110105605 Method of preparing a latanoprost ophthalmic solution and the resulting solution |
| 05/05/2011 | US20110105584 Rtp80il sirna compounds and methods of use thereof |
| 05/05/2011 | US20110105581 Ophthalmic formulations containing substituted gamma lactams and methods for use thereof |
| 05/05/2011 | US20110105574 Pai-1 expression and activity inhibitors for the treatment of ocular disorders |
| 05/05/2011 | US20110105567 Pyrrole Compounds Having Sphingosine-1-Phosphate Receptor Agonist Or Antagonist Biological Activity |
| 05/05/2011 | US20110105551 Analgesics for nasal administration |
| 05/05/2011 | US20110105533 Heterocyclic Sulfonamides, Uses and Pharmaceutical Compositions Thereof |
| 05/05/2011 | US20110105526 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 05/05/2011 | US20110105508 Quinoxaline and quinoline derivatives as kinase inhibitors |
| 05/05/2011 | US20110105482 Compositions of dual thyrointegrin antagonists and use in vascular-associated disorders |
| 05/05/2011 | US20110105458 Fatty acid inhibitors |
| 05/05/2011 | US20110105453 Superoxide Dismutase Mimics For The Treatment Of Optic Nerve And Retinal Damage |
| 05/05/2011 | US20110105450 Ophthalmic formulations of fluticasone and methods of use |
| 05/05/2011 | US20110105447 Novel modulators of calcium release-activated calcium channel |
| 05/05/2011 | US20110105432 Aminocarboxylic acid derivative and medicinal use thereof |
| 05/05/2011 | US20110105426 Compositions and methods for treating corneal inflammation |
| 05/05/2011 | US20110105411 Disease-Associated Proteins |
| 05/05/2011 | US20110105410 Beta-Turn Peptidomimetic Cyclic Compounds for Treating Dry Eye |
| 05/05/2011 | US20110105396 Tgf-beta3 mutants |
| 05/05/2011 | US20110105395 Methods for treating a neurological disorder by peripheral administration of a trophic factor |
| 05/05/2011 | US20110104273 Gastric retentive pharmaceutical compositions for immediate and extended release of phenylephrine |
| 05/05/2011 | US20110104272 Gastric retentive extended-release dosage forms comprising combinations of acetaminophen and phenylephrine |
| 05/05/2011 | US20110104257 Polymorphisms predictive of platinum-coordinating compound-induced ototoxicity |
| 05/05/2011 | US20110104236 Therapeutic compositions for treatment of ocular inflammatory disorders |
| 05/05/2011 | US20110104207 Gyrase inhibitors and uses thereof |
| 05/05/2011 | US20110104206 Methods and compositions for sustained delivery of drugs |
| 05/05/2011 | US20110104181 Modulation of synaptogenesis |
| 05/05/2011 | US20110104172 Inhibitors of gm-csf and il-17 for therapy |
| 05/05/2011 | US20110104169 Regulator genes of angiogenesis, pharmaceutical preparations containing them and their applications |
| 05/05/2011 | US20110104155 Drug delivery to the anterior and posterior segments of the eye using eye drops |
| 05/05/2011 | US20110104154 Single nucleotide polymorphisms and genes associated with age-related macular degeneration |
| 05/05/2011 | US20110104151 Microparticle compositions and methods for treating age-related macular degeneration |
| 05/05/2011 | US20110104139 ANGIOSTATIC COMPOSITIONS COMPRISING TRUNCATED TYROSYL-tRNA SYNTHETASE POLYPEPTIDES AND METHODS OF USING SAME |